From: Changes in ovarian cancer survival during the 20 years before the era of targeted therapy
Total | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
(n = 22,880) | (n = 3740) | (n = 4863) | (n = 6317) | (n = 7960) | ||||||||
No. of cases | % | p-value | No. of cases | % | No. of cases | % | No. of cases | % | No. of cases | % | p-value | |
Age (years) | <.0001 | <.0001 | ||||||||||
< 40 | 3849 | 16.8 | 945 | 25.3 | 910 | 18.7 | 990 | 15.7 | 1004 | 12.6 | ||
40–59 | 12,169 | 53.2 | 1813 | 48.5 | 2526 | 51.9 | 3378 | 53.5 | 4452 | 55.9 | ||
> 59 | 6862 | 30.0 | 982 | 26.3 | 1427 | 29.3 | 1949 | 30.9 | 2504 | 31.5 | ||
SEER Stage | <.0001 | <.0001 | ||||||||||
Localized | 3865 | 16.9 | – | – | – | – | 1683 | 26.6 | 2182 | 27.4 | ||
Regional | 2564 | 11.2 | – | – | – | – | 1053 | 16.7 | 1511 | 19.0 | ||
Distant | 6795 | 29.7 | – | – | – | – | 2843 | 45.0 | 3952 | 49.6 | ||
Unspecified | 9656 | 42.2 | – | – | – | – | 738 | 11.7 | 315 | 4.0 | ||
Primary treatment | <.0001 | <.0001 | ||||||||||
Surgery only | 6007 | 26.3 | 1213 | 32.4 | 1252 | 25.7 | 1626 | 25.7 | 1916 | 24.1 | ||
Chemotherapy only | 1680 | 7.3 | 326 | 8.7 | 371 | 7.6 | 414 | 6.6 | 569 | 7.1 | ||
Surgery + Chemotherapy | 13,262 | 58.0 | 1745 | 46.7 | 2713 | 55.8 | 3805 | 60.2 | 4999 | 62.8 | ||
Others | 1931 | 8.4 | 456 | 12.2 | 527 | 10.8 | 472 | 7.5 | 476 | 6.0 | ||
Histology | <.0001 | <.0001 | ||||||||||
Serous carcinoma | 10,837 | 47.4 | 1459 | 39.0 | 2119 | 43.6 | 3186 | 50.4 | 4073 | 51.2 | ||
Mucinous carcinoma | 4005 | 17.5 | 916 | 24.5 | 1027 | 21.1 | 951 | 15.1 | 1111 | 14.0 | ||
Endometrioid carcinoma | 2191 | 9.6 | 399 | 10.7 | 494 | 10.2 | 580 | 9.2 | 718 | 9.0 | ||
Clear cell carcinoma | 1923 | 8.4 | 164 | 4.4 | 327 | 6.7 | 551 | 8.7 | 881 | 11.1 | ||
Others | 3924 | 17.2 | 802 | 21.4 | 896 | 18.4 | 1049 | 16.6 | 1177 | 14.8 |